HilleVax Statistics
Total Valuation
HilleVax has a market cap or net worth of $93.75 million. The enterprise value is -$41.25 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HilleVax has 49.61 million shares outstanding. The number of shares has increased by 14.46% in one year.
| Current Share Class | 49.61M |
| Shares Outstanding | 49.61M |
| Shares Change (YoY) | +14.46% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 3.74% |
| Owned by Institutions (%) | 51.71% |
| Float | 30.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 25.32, with a Debt / Equity ratio of 0.16.
| Current Ratio | 25.32 |
| Quick Ratio | 24.38 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.91 |
Financial Efficiency
Return on equity (ROE) is -54.64% and return on invested capital (ROIC) is -21.52%.
| Return on Equity (ROE) | -54.64% |
| Return on Assets (ROA) | -20.31% |
| Return on Invested Capital (ROIC) | -21.52% |
| Return on Capital Employed (ROCE) | -46.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$7.61M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.34% in the last 52 weeks. The beta is 0.77, so HilleVax's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -86.34% |
| 50-Day Moving Average | 1.72 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 59.26 |
| Average Volume (20 Days) | 285,016 |
Short Selling Information
The latest short interest is 1.85 million, so 3.74% of the outstanding shares have been sold short.
| Short Interest | 1.85M |
| Short Previous Month | 1.52M |
| Short % of Shares Out | 3.74% |
| Short % of Float | 6.10% |
| Short Ratio (days to cover) | 6.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -80.09M |
| Pretax Income | -156.27M |
| Net Income | -106.50M |
| EBITDA | -78.42M |
| EBIT | -80.09M |
| Earnings Per Share (EPS) | -$2.15 |
Full Income StatementBalance Sheet
The company has $159.54 million in cash and $24.04 million in debt, giving a net cash position of $135.50 million or $2.73 per share.
| Cash & Cash Equivalents | 159.54M |
| Total Debt | 24.04M |
| Net Cash | 135.50M |
| Net Cash Per Share | $2.73 |
| Equity (Book Value) | 150.91M |
| Book Value Per Share | 3.04 |
| Working Capital | 159.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$88.51 million and capital expenditures -$369,000, giving a free cash flow of -$88.88 million.
| Operating Cash Flow | -88.51M |
| Capital Expenditures | -369,000 |
| Free Cash Flow | -88.88M |
| FCF Per Share | -$1.79 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |